Mr. Harish
Natarajan appointed as the new President and COO of Strand Life Sciences.
Strand Life Sciences, a clinical
diagnostics company and a leader in precision medicine in India, announced the
appointment of Mr. Harish Natarajan as President (Clinical Diagnostics
Business) and Chief Operating Officer with effect from 21st December
2018. Harish brings to Strand Life Sciences, a wealth of leadership experience
that spans multiple healthcare assignments across India and South East Asia.
Over his 28 years in the field, he has spent 15 years in healthcare and 12
years as CEO of organisations such as Baxter, Bausch and
Lomb and HCL Healthcare. He is passionate about creating a proactive healthcare
system that is rooted in wellness, early detection and primary care. Early
diagnosis is critical to an effective cure and as the new COO at the helm of
Strand Life Sciences, Harish is committed to the company’s motto of new
generation healthcare with diagnostic reports that matter.
Dr. Ramesh Hariharan, PhD, FASc, Co-Founder and Chief Executive
Officer of Strand Life Sciences was quoted, “Strand Life Sciences is now an
end-to-end diagnostics player in India, offering solutions in advanced Next
Generation Sequencing (NGS) diagnostics; specialised diagnostics for Oncology,
women's health and infectious diseases, data analytics-based wellness
predictions and the entire range of routine tests. Our geographical reach now
spans most major Indian cities, and with Harish at the helm, our strong R&D
and data sciences teams will continue to drive innovative growth as well as
partnerships with major international players like Quest”.
No comments:
Post a Comment